Live Breaking News & Updates on Company Spokeperson

Stay updated with breaking news from Company spokeperson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
Biomerica, Inc.January 15, 2021 GMT
Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021

FDA actively reviewing Company’s EUA submission for its first of its kind “at-home” Blood Collection kit used with the Biomerica COVID-19 IgG ELISA Lab Test system

Simple to use 15-minute COVID-19 Antigen Rapid Test, which now has CE Mark, receives first large orders
IRVINE, Calif., Jan. 15, 2021 (GLOBE NEWSWIRE) Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced financial results for its second quarter of fiscal year 2021, which ended November 30, 2020. ....

United States , Zackary Irani , Biomerica Infoods , Company Spokeperson , Lab Test , Drug Administration , University Of Michigan , Beth Israel Deaconess Medical Center Inc , Company Emergency Use Authorization , Harvard Medical School Teaching Hospital , Biomerica Inc , Rapid Test , Emergency Use Authorization , Whole Blood Collection Card , Antigen Test , Irritable Bowel Syndrome , Beth Israel Deaconess Medical Center , Houston Methodist , Texas Health Science Center , Private Securities Litigation Reform Act , Technology Issues , Products And Services , Coronavirus Pandemic , Product Testing , Technology Law And Ethics , Globe Newswire ,

Biomerica's Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark Nasdaq:BMRA

Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement (specificity) as compared to lab-based molecular PCR tests
IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it has received CE Mark for its new COVID-19 Rapid Antigen Test for detection of COVID-19 infection. The Company has already received its first European orders and plans to ship the first part of these orders in the coming weeks. The Company will now begin marketing this product broadly in Europe and other regions outside of the US.
Biomerica’s new COVID-19 Antigen Rapid Test is highly portable, affordable, and provides results in 15 minutes with no equipment required to perform or read the test. Because this test can be performed by doctors, nurses, school nurses, and medical assistants, the Biomerica COVID-19 Rapid Antigen Test can be per ....

United States , Biomerica Infoods , Zack Irani , Company Spokeperson , Biomerica Inc , Antigen Test , Rapid Test , Irritable Bowel Syndrome , Private Securities Litigation Reform Act , Nasdaq Bmra , Covid 19 , Covid 19 Antigen Test , Rapid Covid 19 Test , ஒன்றுபட்டது மாநிலங்களில் , ஸ்யாக் இரணி , விரைவான சோதனை , எரிச்சல் குடல் நோய்க்குறி , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,